Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06522347

Mycobacteria Registry Study: Prospective Observational Study in Austria

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:

What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?

Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Non-Tuberculous Mycobacterial Pneumonia Actinomycetales Infections Bacterial Infections Bacterial Infections and Mycoses Gram-Positive Bacterial Infections Infections Mycobacterium Infections Tuberculosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinik Hietzing, Vienna, Austria

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
  • individuals aged 18 years or older
  • written informed consent

Exclusion criteria

  • to not comprehend and rightfully judge participation

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: 30 years

    Mortality due to tuberculosis or NTM infection in Austria

Secondary outcomes

  1. Prevalence

    Time frame: 30 years

    Prevalence of mycobacterial infections in Austria

  2. Patient cohort

    Time frame: 30 years

    Description of the patient cohort

  3. Risk factors

    Time frame: 30 years

    Identification of risk factors for treatment failure and complications

Sponsors and collaborators

Lead sponsor

Ludwig Boltzmann Institute for Lung Health

Other

Collaborators

  • Sigmund Freud PrivatUniversitat

Registry information

Important dates

Study start
2023
Primary completion
2053
Study completion
2053
First posted
Jul 26, 2024
Registry last updated
Jul 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.